Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey

BackgroundThere is a paucity of real-world data on patients with interstitial lung diseases (ILDs) that are progressive, other than idiopathic pulmonary fibrosis (IPF), including treatment patterns and attitudes toward treatment. This study aimed to investigate the diagnosis, clinical characteristic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hidekata Yasuoka, Yuko Waseda, Yuko Kaneko, Masateru Okazaki, Ryoko Iwasaki, Shoko Nagata, Mark Small, Haruyuki Ishii
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Medicine
Subjects:	idiopathic pulmonary fibrosis progressive pulmonary fibrosis interstitial lung disease antifibrotics treatment real-world data
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1526531/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive factors of fibrotic interstitial lung abnormality on high-resolution computed tomography scans: a prospective observational study
by: Kazuya Ichikado, et al.
Published: (2025-01-01)

Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
by: Athol U. Wells, et al.
Published: (2024-12-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

Carboplatin in combination with etoposide for advanced small cell lung cancer complicated with idiopathic interstitial pneumonia: a single-arm phase II study
by: Masaru Matsumoto, et al.
Published: (2025-01-01)

Quality of life in idiopathic pulmonary fibrosis in Latin American countries
by: H. Aguilar-Duran, et al.
Published: (2025-01-01)

Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis
by: Tan Y, et al.
Published: (2025-02-01)

Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis
by: Wonseok Whi, et al.
Published: (2025-01-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
by: Zhe Chen, et al.
Published: (2025-01-01)

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients
by: Agata Maciejewska, et al.
Published: (2025-01-01)

Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)

Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation
by: Mohamed F. AbdelGhany, et al.
Published: (2025-01-01)

Nomogram model using serum Club cell secretory protein 16 to predict prognosis and acute exacerbation in patients with idiopathic pulmonary fibrosis
by: Yaqiong Tian, et al.
Published: (2025-01-01)

Traditional Chinese Medicine Ion Introduction Therapy Reduces the Incidence of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study
by: Wang Y, et al.
Published: (2025-01-01)

Machine learning potential predictor of idiopathic pulmonary fibrosis
by: Chenchun Ding, et al.
Published: (2025-01-01)

Blood urea nitrogen-to-albumin ratio as a new prognostic indicator of 1-year all-cause mortality in patients with IPF
by: Shaobo Ge, et al.
Published: (2025-01-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial
by: Aijun Zhang, et al.
Published: (2025-01-01)

Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis
by: Sebastian Nowak, et al.
Published: (2025-01-01)

Pulmonary fibrosis as the sole manifestation of anti-Ku antibody positivity in the absence of myositis: A case report
by: Angelo Nigro, Dr.
Published: (2025-01-01)

Treatable traits in idiopathic pulmonary fibrosis: focus on respiratory tract infections—a systematic review and a meta-analysisResearch in context
by: Zsombor Matics, et al.
Published: (2025-01-01)

Beyond Tumors: The Pivotal Role of TRIM Proteins in Chronic Non-Tumor Lung Diseases
by: Huang X, et al.
Published: (2025-02-01)

METTL14-mediated m6A modification of DDIT4 promotes its mRNA stability in aging-related idiopathic pulmonary fibrosis
by: Dan Li, et al.
Published: (2025-12-01)

Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report
by: Xiaoli Wang, et al.
Published: (2025-02-01)

Elucidating the causal associations and mechanisms between circulating immune cells and idiopathic pulmonary fibrosis: new insights from Mendelian randomization and transcriptomics
by: Han Yang, et al.
Published: (2025-01-01)

PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: Mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis
by: Ganggang Li, et al.
Published: (2025-01-01)

Effects of Sildenafil and Vitamin E on Paraquat-Induced Pulmonary Fibrosis in Rats
by: Fouziyeh Siahpour, et al.
Published: (2024-12-01)

Common biomarkers of idiopathic pulmonary fibrosis and systemic sclerosis based on WGCNA and machine learning
by: Ning Shan, et al.
Published: (2025-01-01)

Identifying health risk determinants and molecular targets in patients with idiopathic pulmonary fibrosis via combined differential and weighted gene co-expression analysis
by: Abu Tayab Moin, et al.
Published: (2025-01-01)

Commonly prescribed medications and risk of pneumonia and all-cause mortality in people with idiopathic pulmonary fibrosis: a UK population-based cohort study
by: Ann D. Morgan, et al.
Published: (2025-01-01)

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension
by: Shameek Gayen, et al.
Published: (2025-02-01)

Epithelial stem cells from human small bronchi offer a potential for therapy of idiopathic pulmonary fibrosisResearch in context
by: Zeyu Liu, et al.
Published: (2025-02-01)

Longitudinal changes in the 6-minute walk test and the Glittre-activities of daily living test in adults with cystic fibrosis
by: Vera Lucia Barros Abelenda, et al.
Published: (2025-01-01)

CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
by: Jiwei Hou, et al.
Published: (2025-01-01)

Contribution of cuproptosis and immune-related genes to idiopathic pulmonary fibrosis disease
by: Chengji Jin, et al.
Published: (2025-02-01)

Health-related quality of life and health state utility value in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
by: Guixiang Zhao, et al.
Published: (2025-01-01)

HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats
by: Rathasapa Patarat, et al.
Published: (2025-01-01)

MSC-derived exosome ameliorates pulmonary fibrosis by modulating NOD 1/NLRP3-mediated epithelial-mesenchymal transition and inflammation
by: Wei Chen, et al.
Published: (2025-01-01)

The link between smoking, emphysema, and fibrosis: A retrospective cohort study
by: Liying Zhai, et al.
Published: (2024-07-01)

Autologous precision-cut lung slice co-culture models for studying macrophage-driven fibrosis
by: So-Yi Chang, et al.
Published: (2025-01-01)